ArticleClinicoEconomics and outcomes research : CEOR2025
Healthcare Costs and Treatment Patterns of Triplet Therapies in Relapsed/Refractory Multiple Myeloma: Real World Evidence from Italy.
Valentina Perrone et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.